Development of a rVSV-Vectored Vaccine for Lassa Virus: Nonhuman Primate Efficacy and Immunogenicity Studies

Project: Research project

Project Details

StatusActive
Effective start/end date1/1/2112/1/24

Funding

  • Emergent Product Development Gaithersburg, Inc: $1,787,896.00